Allisartan Isoproxil
Allisartan Isoproxil is a pharmaceutical drug with 5 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
5
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
66.7%
2 of 3 finished
33.3%
1 ended early
2
trials recruiting
5
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Intensive Management of Blood Pressure and Cholesterol in Elderly Chinese With Hypertension and Atrial Fibrillation
Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes
Antihypertensive Treatment in Masked Hypertension
To Assess Allisartan Isoproxil/Sustained-Release Indapamide in Patients With Essential Hypertension Uncontrolled With Allisartan Isoproxil
Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes-----renal Substudy
Clinical Trials (5)
Intensive Management of Blood Pressure and Cholesterol in Elderly Chinese With Hypertension and Atrial Fibrillation
Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes
Antihypertensive Treatment in Masked Hypertension
To Assess Allisartan Isoproxil/Sustained-Release Indapamide in Patients With Essential Hypertension Uncontrolled With Allisartan Isoproxil
Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes-----renal Substudy
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5